Skip to main content
NIH funding notice PAR-21-141

AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed)

Closed on September 7, 2023.

Posted
March 4, 2021
Close date
September 7, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $797,172 in first-year total cost, median $398,586.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 (J2)]2

Most frequent institutions

  1. MASSACHUSETTS GENERAL HOSPITAL1
  2. UNIVERSITY OF SOUTHERN CALIFORNIA1
Competing awards under PAR-21-141 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022NIA/AA for Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (NIA/AA IMPACT-AD Course)1R25AG076392-01GRILL, JOSHUARAMAN, REMAUNIVERSITY OF SOUTHERN CALIFORNIA, CA$426,043ZAG1
2022Diversifying and Strengthening Dementia Palliative Care Clinical Trials1R25AG076388-01KUTNER, JEAN SPOLLAK, KATHRYN IRITCHIE, CHRISTINE SMASSACHUSETTS GENERAL HOSPITAL, MA$371,129ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.